Immediate Impact
23 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Maren Keller being referenced
NOGGO Ov-42/MAMOC: Rucaparib maintenance after bevacizumab maintenance following carboplatin-based first line-chemotherapy in ovarian cancer patients.
2020
Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Maren Keller | 48 | 43 | 28 | 67 | 59 | 32 | 204 | |
| G. Sabetta | 23 | 9 | 43 | 143 | 42 | 27 | 274 | |
| Marlena Typiak | 7 | 15 | 42 | 19 | 88 | 24 | 281 | |
| Sócrates Aedo | 8 | 78 | 42 | 9 | 12 | 43 | 281 | |
| Atsumi Tsuji‐Hosokawa | 11 | 9 | 20 | 41 | 17 | 30 | 230 | |
| Merih Bayram | 35 | 24 | 31 | 6 | 14 | 46 | 281 | |
| Fatma Dursun | 30 | 6 | 24 | 9 | 13 | 34 | 201 | |
| Alina Sokup | 22 | 42 | 32 | 7 | 12 | 20 | 257 | |
| J. Gillen | 21 | 31 | 17 | 4 | 19 | 16 | 151 | |
| Tinka Hovnik | 6 | 12 | 28 | 42 | 36 | 25 | 269 | |
| N. Gebbia | 15 | 113 | 69 | 10 | 35 | 25 | 238 |
All Works
Loading papers...